Minimally invasive pelvic exenteration for primary or recurrent locally advanced rectal cancer:A glimpse into the future  

作　　者：Dimitrios Kehagias Charalampos Lampropoulos Ioannis Kehagias 

机构地区：[1]Department of General Surgery,General University Hospital of Patras,Patras 26504,Greece [2]Intensive Care Unit,Saint Andrew’s General Hospital,Patras 26335,Greece [3]Division of Bariatric and Metabolic Surgery,Department of Surgery,University of Patras,Patras 26504,Greece

出　　处：《World Journal of Gastrointestinal Surgery》2024年第7期1960-1964,共5页世界胃肠外科杂志（英文版）（电子版）

摘　　要：Surgeons have grappled with the treatment of recurrent and T4b locally advanced rectal cancer(LARC)for many years.Their main objectives are to increase the overall survival and quality of life of the patients and to mitigate postoperative complications.Currently,pelvic exenteration(PE)with or without neoadjuvant treatment is a curative treatment when negative resection margins are achieved.The traditional open approach has been favored by many surgeons.However,the technological advancements in minimally invasive surgery have radically changed the surgical options.Recent studies have demonstrated promising results in postoperative complications and oncological outcomes after robotic or laparoscopic PE.A recent retrospective study entitled“Feasibility and safety of minimally invasive multivisceral resection for T4b rectal cancer:A 9-year review”was published in the World Journal of Gastrointestinal Surgery.As we read this article with great interest,we decided to delve into the latest data regarding the benefits and risks of minimally invasive PE for LARC.Currently,the small number of suitable patients,limited surgeon experience,and steep learning curve are hindering the establishment of minimally invasive PE.

关 键 词：Locally advanced rectal cancer Pelvic exenteration Multivisceral resection Minimally invasive surgical procedures Robotic surgical procedures 

分 类 号：R735.37[医药卫生—肿瘤]